Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by Mbxwatcheron Dec 01, 2022 10:01pm
262 Views
Post# 35145193

RE:RE:RE:RE:RE:RE:RE:Unbelievable

RE:RE:RE:RE:RE:RE:RE:Unbelievable A miss could be a decrease on the top line or a loss on the bottom line, both of which I think could happen in the 4th quarter.
I also don't think they have met the objectives in either of the vtm or QAPs divisions they set out.
it doesn't mean that I think they won't, it means it won't be reflected in the 4th quarter. In my estimation ( which could be wrong) that's what I read into. Amerindian comments 

since I agree with you that they will achieve these objectives and it's a timing thing I continue to hold. My comment on buying in the new year has more to do with personal availability of funds than trying to time the bottom

i agree that tax loss selling could well be a cause of the most recent weakness and admit I hadn't considered that

Thank you all for the dialogue 
<< Previous
Bullboard Posts
Next >>